ProMIS Neurosciences Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMN and other ETFs, options, and stocks.About PMN
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.
CEONeil K. Warma
CEONeil K. Warma
Employees7
Employees7
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2004
Founded2004
Employees7
Employees7
PMN Key Statistics
Market cap17.69M
Market cap17.69M
Price-Earnings ratio-0.44
Price-Earnings ratio-0.44
Dividend yield—
Dividend yield—
Average volume1.00M
Average volume1.00M
High today$0.43
High today$0.43
Low today$0.2611
Low today$0.2611
Open price$0.30
Open price$0.30
Volume4.00M
Volume4.00M
52 Week high$1.59
52 Week high$1.59
52 Week low$0.2611
52 Week low$0.2611
Stock Snapshot
As of today, ProMIS Neurosciences Inc.(PMN) shares are valued at $0.33. The company's market cap stands at 17.69M, with a P/E ratio of -0.44.
On 2025-11-25, ProMIS Neurosciences Inc.(PMN) stock moved within a range of $0.26 to $0.43. With shares now at $0.33, the stock is trading +27.3% above its intraday low and -22.7% below the session's peak.
Trading volume for ProMIS Neurosciences Inc.(PMN) stock has reached 4M, versus its average volume of 1M.
The stock's 52-week range extends from a low of $0.26 to a high of $1.59.
The stock's 52-week range extends from a low of $0.26 to a high of $1.59.
People also own
Based on the portfolios of people who own PMN. This list is generated using Robinhood data, and it’s not a recommendation.